AI in Biomedicine and Health: Balancing Innovation and Integrity

Health is the foundation of life — this becomes increasingly important as populations age and chronic diseases rise.

From a biomedical research perspective, artificial intelligence (AI) is transforming our understanding of disease and enabling new approaches to prevention, diagnosis, and treatment. By integrating AI into fields such as genomics, proteomics, and systems biology, researchers can identify early biomarkers, predict disease progression, and develop interventions before symptoms appear.

However, the transformative potential of AI in healthcare depends not only on innovation but also, on the ability of healthcare systems to evolve. If healthcare systems are primarily designed to treat diseases rather than prevent them, deploying AI without addressing underlying structural challenges risks placing additional strain on these systems.

At the same time, the rise of an “infodemic” highlights the importance of evidence-based decision-making, trust, and transparency in both AI systems and the institutions responsible for their use.

Basic research remains the foundation of innovation, with academia generating new knowledge and industry translating discoveries into practical applications.

Ultimately, the value of AI in healthcare lies not in its technological sophistication, but in its ability to improve health outcomes. Realizing this potential requires closer integration of biomedical research, innovation, and clinical practice to make prevention, early detection, and personalized care accessible to everyone.